Author

Lars Jürgenliemke

University of BonnORCID 0009-0001-2701-9276Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Evi KostenisiD· 2 shared Agnes SchröderiD· 1 shared Amira NaimiiD· 1 shared Andreas Ulrich LindneriD· 1 shared Anil AkbaliD· 1 shared Annika Frauenstein· 1 shared Anushka KudaliyanageiD· 1 shared Benedikt O. GanseniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Evi KostenisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintAug 4, 2026

Discovery of a Cell-Permeable Gi-Signaling Inhibitor

Amira Naimi, Tim Berger, Philipp Dahlhaus…·Raphael Reher

This paper discovers NHAP, a fungal metabolite that selectively inhibits Gi-signaling, demonstrating functional blockade in cardiomyocytes without cytotoxicity.

DOI 10.64898/2026.08.02.742274

metabolomicsexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivPreprintFeb 25, 2026

NLRP3 activators disrupt the endocytic AP2 complex and plasma membrane signaling

Stefan Ebner, Kshiti Meera Phulphagar, Yubell Alvarez…·Felix Meissner

The paper shows NLRP3 activators disrupt the AP2 complex and impair plasma membrane signaling, leading to inflammation and cell death.

DOI 10.64898/2026.02.24.707400

humanproteomics

𝕏 PostBluesky